Skip to main content

Application of Single-Domain Antibodies in Tumor Histochemistry

  • Protocol
  • First Online:
Book cover Single Domain Antibodies

Part of the book series: Methods in Molecular Biology ((MIMB,volume 911))

  • 4965 Accesses

Abstract

High avidity, pentameric, single-domain antibodies, oligomerized through the B subunit of verotoxin, are excellent immunohistochemical reagents. The resulting molecules are termed pentabodies. Here, we describe the immunostaining of tissue sections with ES1, a pentabody recognizing CEACAM6 which is overexpressed in several cancers. The advantages of pentabodies, compared to conventional antibody reagents, in immunohistochemical studies are highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Taussig MJ et al (2007) ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods 4:13–17

    Article  PubMed  CAS  Google Scholar 

  2. Dübel S et al (2010) Generating recombinant antibodies to the complete human proteome. Trends Biotechnol 28:333–339

    Article  PubMed  Google Scholar 

  3. Zhang J et al (2004) Pentamerization of single-domain antibodies from phage libraries: a novel strategy for generation of high-avidity antibody reagents. J Mol Biol 335:49–56

    Article  PubMed  CAS  Google Scholar 

  4. Zhang J et al (2004) A pentavalent single-domain antibody approach to tumor antigen discovery and the development of novel proteomics reagents. J Mol Biol 341:161–169

    Article  PubMed  CAS  Google Scholar 

  5. Mai KT et al (2006) ES1, a new lung carcinoma antibody – an immunohistochemical study. Histopathology 49:515–522

    Article  PubMed  CAS  Google Scholar 

  6. Blumenthal RD et al (2007) Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer 7:2

    Article  PubMed  Google Scholar 

  7. Duxbury MS et al (2004) CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Br J Cancer 91:1384–1390

    Article  PubMed  CAS  Google Scholar 

  8. Tanha J et al (2002) Selection by phage display of llama conventional VH fragments with heavy chain antibody VHH properties. J Immunol Methods 263:97–109

    Article  PubMed  CAS  Google Scholar 

  9. Bryant RJ, Banks PM, O’Malley DP (2006) Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders. Histopathology 48:505–515

    Article  PubMed  CAS  Google Scholar 

  10. Du MZ et al (2004) TTF-1 expression is specific for lung adenocarcinoma in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 35:825–831

    Article  PubMed  CAS  Google Scholar 

  11. Kononen J et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847

    Article  PubMed  CAS  Google Scholar 

  12. Jantscheff P et al (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 21:3638–3646

    Article  PubMed  CAS  Google Scholar 

  13. Revets H, De Baetselier P, Muyldermans S (2004) Nanobodies as novel agents for cancer therapy. Expert Opin Biol Ther 5:111–124

    Article  Google Scholar 

Download references

Acknowledgments

We thank Jianbing Zhang for providing the rabbit anti-verotoxin antiserum. The authors declare no financial conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kien T. Maik .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Maik, K.T., MacKenzie, C.R. (2012). Application of Single-Domain Antibodies in Tumor Histochemistry. In: Saerens, D., Muyldermans, S. (eds) Single Domain Antibodies. Methods in Molecular Biology, vol 911. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-968-6_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-968-6_33

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-967-9

  • Online ISBN: 978-1-61779-968-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics